Evolving Clinical Paradigms for LDL Lowering - Focus on Efficacy, Implications, Side Effects, and Safety Results of Clinical Trials Evaluating PCSK9 Inhibition - James M. McKenney, PharmD

Evolving Clinical Paradigms for LDL Lowering - Focus on Efficacy, Implications, Side Effects, and Safety Results of Clinical Trials Evaluating PCSK9 Inhibition - James M. McKenney, PharmD


Published

August 9, 2016

Created by

CMEducation Resources symposium